Issue: May 2015
April 20, 2015
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Trial Scorecard: MATRIX
Issue: May 2015
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Comparison of radial access vs. femoral access and of bivalirudin vs. unfractionated heparin with or without glycoprotein IIb/IIIa inhibitors in patients with ACS undergoing angiography and PCI.